NSE IPO 2026: DRHP Filed - What It Means for Investors and Unlisted Shareholders

On June 17, 2026, the National Stock Exchange of India filed its Draft Red Herring Prospectus (DRHP) with SEBI — formally kicking off what could become the largest initial public offering in Indian capital market history, estimated at approximately ₹30,000 crore.

NSE has been attempting to list since 2016. A decade of regulatory gridlock, the co-location controversy, governance investigations, and a ₹1,387 crore settlement payment later, SEBI issued its No Objection Certificate on January 30, 2026. The DRHP filing on June 17 is the next formal milestone — and for investors who have held NSE unlisted shares in the OTC market, it is the moment they have been waiting for.

This article covers what the DRHP actually discloses, what it means for unlisted shareholders, what retail investors should watch, and the honest valuation questions the filing raises.

The headline fact: At an estimated ₹30,000 crore, the NSE IPO would surpass Hyundai Motor India's ₹27,859 crore issue (2024) to become the largest IPO in Indian capital market history. Given that NSE itself enabled every major IPO in India for three decades, there is a historic irony to it finally submitting to the same process.

The 100% OFS Structure: What It Means and Why It Matters

The NSE IPO is structured entirely as an Offer for Sale — existing shareholders are selling up to 14.89 crore shares, and NSE itself is issuing zero new shares. The company will receive no proceeds from the IPO.

What this means for investors:

NSE does not need the money. With an EBITDA margin of 66.85%, net margins of 55%, ROE of 32.98%, and a robust balance sheet, NSE has no requirement for fresh capital. The OFS structure confirms this — the listing is a shareholder exit and price discovery event, not a fund-raise for growth.

The OFS has no dilutive effect. Since no new shares are being created, existing shareholders' percentage stakes are not diluted by the IPO. The total share count remains unchanged.

The proceeds go to institutional shareholders, not to NSE. Every rupee raised in this OFS — estimated at ₹25,000–30,000 crore — goes to the selling shareholders (SBI, Bank of Baroda, GIC, New India Assurance, and others) proportionally to their shares sold. NSE's P&L and balance sheet are unaffected by the IPO proceeds.

What this means for post-listing NSE: NSE's business will look identical after listing to before — same revenues, same expenses, same cash flows. The listing creates liquidity, price transparency, and broader ownership access. It does not inject growth capital or change business direction.

Key shareholders NOT selling:

LIC (Life Insurance Corporation) — Largest single shareholder at 10.72% stake; not participating in OFS

Premji Invest — Technology billionaire Azim Premji's family office; holding

Radhakishan Damani — Retail billionaire and investor; holding

Canada Pension Plan Investment Board (CPPIB) — Institutional investor; holding

Morgan Stanley — International financial institution; holding

The signal from who is NOT selling: LIC holding its full stake, and strategic investors like Premji Invest and Radhakishan Damani retaining positions, signals continued conviction in NSE's long-term value even at current unlisted valuations. The sellers are primarily government-affiliated institutions that have long-held stakes and are engaging in routine portfolio rebalancing — not a vote against NSE's future.

The FY26 earnings decline requires honest explanation: NSE's revenue fell 3.1% and PAT fell 15.5% in FY26. The primary cause: SEBI's F&O tightening regulations implemented in late 2024 and 2025 — specifically the expiry-day restrictions and lot size increases for derivatives contracts — reduced F&O trading volumes significantly. Since NSE derives a substantial portion of its revenue from transaction charges on equity derivatives (one of the most active derivatives markets globally), the volume reduction directly hit the top line.

This matters for valuation: if NSE is being valued at ~₹5 lakh crore, that implies a P/E multiple of approximately 48-49x FY26 earnings. That is not cheap — particularly for a year in which earnings declined. The valuation case rests on the assumption that FY26 represents a trough year for derivatives volumes due to regulatory tightening, and that earnings will recover or grow from here.

NSE Valuation: Is ₹5 Lakh Crore Justified?

This is the central question for anyone evaluating the NSE IPO — whether as a retail IPO applicant or as a holder of unlisted shares.

The unlisted market implies: ~₹5 lakh crore total market cap at current OTC prices of ₹1,950–2,050 per share.

The P/E multiple implied: At ₹10,302 crore FY26 PAT, ₹5 lakh crore market cap = 48-49x P/E on FY26 earnings.

Listed peer comparison:

The honest verdict on valuation:

NSE at 48-49x FY26 P/E is in the range of its listed Indian peers (BSE at 55-60x, CDSL at 50-55x) — suggesting it is not obviously overpriced relative to India's exchange infrastructure sector, which trades at premium multiples reflecting monopolistic positioning and high-margin business models.

However, there are two important valuation caveats:

FY26 is a trough year. If F&O volumes recover from regulatory tightening, NSE's earnings could revert to FY25 levels (₹12,188 crore) or higher — which would imply a trailing P/E of ~41x. At FY25 earnings, the valuation looks more reasonable.

No promoter structure carries a governance risk premium. NSE's diffuse shareholding with no identifiable promoter — unusual for a systemically important institution — may result in a valuation discount at the institutional book-building stage that the current unlisted OTC market has not yet priced.

What NSE Unlisted Shareholders Need to Know

If you currently hold NSE shares purchased in the unlisted/OTC market, the DRHP filing has specific implications you need to understand:

OFS eligibility cut-off date: The DRHP specifies that only shares held continuously since June 15, 2025 are eligible for inclusion in the OFS. This means if you purchased NSE unlisted shares after June 15, 2025, your shares may not be eligible for the OFS — you would need to wait for the secondary market on BSE post-listing to exit.

Your position as a non-OFS shareholder: Even if you cannot participate in the OFS, you remain a shareholder. On listing, your unlisted shares will be converted to regular demat shares tradeable on BSE — providing the liquidity you have been waiting for.

The price risk between now and listing: The current OTC unlisted market price (~₹1,950–2,050) reflects investor expectations of a favourable IPO outcome. If SEBI's observations require significant changes, or if the price band is set materially below current OTC prices, the unlisted market price could correct before listing. The HDB Financial lesson from 2025 — where the unlisted market price of ~₹1,250 was significantly above the eventual IPO price of ₹740 — is directly relevant context.

What to watch: The RHP price band announcement (expected August–September 2026) is the key moment. If the IPO price band is set at or above current unlisted market prices, existing holders benefit. If below, there could be a correction before listing.

Key Risks Disclosed in the NSE DRHP

The DRHP contains explicit risk disclosures that every investor should understand:

1. Derivatives revenue concentration: A substantial share of NSE's revenue comes from F&O transaction charges. SEBI's 2024-25 regulatory tightening on derivatives (expiry restrictions, lot size increases) already caused a 15.5% PAT decline in FY26. Any further regulatory action on F&O volumes is the single largest risk to NSE's earnings.

2. Residual co-location regulatory overhang: Settlement applications for legacy co-location matters are still pending before SEBI. While NSE paid ₹1,387 crore to settle the primary matter, the DRHP acknowledges ongoing regulatory monitoring. New disclosures in the SEBI observation letter could surface additional issues.

3. No identifiable promoter: NSE has a diffuse, no-promoter shareholding structure — unusual for an institution of this systemic importance. This creates potential governance concerns around accountability and strategic decision-making continuity.

4. Technology risk: NSE is classified as Critical Information Infrastructure. The February 2021 trading outage (five hours of trading halt) is cited in the DRHP as a reference risk event alongside ongoing cybersecurity threats.

5. Competition from BSE: BSE has been gaining market share in specific segments, particularly the equity cash segment and certain derivatives categories. While NSE retains overwhelming dominance in the overall derivatives market, competitive pressure at the margin is a structural risk.

6. FY26 earnings decline is the base: The valuation is being set against a year of declining earnings. If FY27 does not show earnings recovery, the P/E multiple expands further, increasing overvaluation risk.

NSE IPO vs BSE, CDSL, MCX: The Peer Valuation Comparison

The most useful valuation framework for NSE is not an absolute P/E but a relative comparison to listed Indian market infrastructure peers — since exchange and depository businesses trade at structurally different multiples than industrial companies.

BSE and CDSL both trade at 50-60x TTM earnings currently — reflecting the market's willingness to pay premium multiples for near-monopoly infrastructure businesses with high margins and structural tailwinds from India's expanding investor base. At 48-49x FY26 P/E, NSE is at the lower end of this range for its Indian peers — arguably reflecting a modest discount for the no-promoter structure and the regulatory history.

The key question for valuation: Is FY26 the earnings trough, or will F&O regulatory tightening continue to suppress volumes? If FY27 earnings recover to even ₹11,500–12,000 crore, the forward P/E at ₹5 lakh crore valuation drops to approximately 42-43x — within the reasonable range for a market infrastructure business with 55%+ net margins and structural growth tailwinds.

What Retail Investors Should Watch Before Applying

1. The RHP price band — not the DRHP. The DRHP has no price band. The actual investment decision should only be made when the RHP discloses the price band and lot size — expected August–September 2026. Applying based on current OTC prices or "expected valuations" is premature.

2. Subscription category allocation. NSE IPO at ₹30,000 crore will have a retail (non-HNI) portion of approximately 10% of the issue (₹3,000 crore) under standard SEBI allocation norms for mainboard issues — with QIBs getting 50% and NIIs getting 15%. Given likely oversubscription, retail allotment probability may be low.

3. FY27 earnings outlook. If the F&O regulatory environment stabilises and derivatives volumes recover in FY27, NSE's earnings recovery story strengthens the investment case at IPO price. If further F&O curbs emerge, the earnings decline continues.

4. The co-location settlement applications. Any adverse SEBI observations on pending co-location settlement matters could delay the IPO timeline or require additional disclosures — a wildcard in the September-October timeline estimate.

5. Listing-day expectations vs long-term holding. For long-term investors, NSE's structural position as India's dominant exchange infrastructure, with 55% net margins and growing retail participation as the underlying tailwind, makes it a compelling long-term holding. For listing-day flippers: at current OTC prices, there may not be significant GMP upside if the IPO is priced close to the unlisted market level.

Ultra's Position: NSE IPO From an Investment Standpoint

Applying the audit principle — Ultra's specific view, not hype:

The NSE IPO is a genuine investment opportunity in one of India's most important financial institutions — but the price band, not the DRHP, is what determines whether it is a good investment.

The business quality is not in question. NSE has 55% net margins, 32.98% ROE, near-monopoly position in India's derivatives market, and structural tailwinds from a rapidly expanding retail investor base. These are exceptional fundamentals. The listing also provides genuine financial market infrastructure equity exposure — a category that was previously inaccessible to most investors.

The valuation discipline required: At ~48-49x FY26 P/E on a year of declining earnings, the IPO is priced for perfection on earnings recovery. The HDB Financial lesson is directly applicable here — unlisted market prices are set by OTC demand dynamics, not by institutional book-building. The IPO price band, once announced, will be set by a syndicate of 20 investment banks including Morgan Stanley, J.P. Morgan, and Kotak Mahindra Capital — significantly more rigorous valuation discipline than the OTC market applies. If the price band is set at a discount to current OTC prices (as happened with HDB Financial), unlisted holders will face a markdown.

For existing unlisted shareholders: Do not treat the DRHP filing as a signal to buy more at current OTC prices. Wait for the RHP price band. If the band is at or above current OTC levels, your position benefits directly. If below, avoid averaging down in the OTC market — buy instead after listing at the market price if the fundamentals justify it.

For retail IPO investors: Apply for the long term if the price band implies reasonable forward multiples (below 45x on an FY27 earnings recovery estimate). Do not apply with listing-day flipping in mind at a ₹30,000 crore issue size where QIB and NII demand will dominate and retail allotment will be thin.

For the full NSE unlisted share price analysis and OTC market guide, read: NSE Pre-IPO Price Guide: How to Track & Invest Before the Buzz

For the broader unlisted shares framework including the HDB Financial lesson, read: Best Unlisted Shares to Buy in India 2026: Screened & Ranked

FAQs

Q1. When did NSE file its DRHP for the IPO?

NSE filed its Draft Red Herring Prospectus (DRHP) with SEBI on June 17, 2026 — formally initiating the IPO process. This follows SEBI's No Objection Certificate (NOC) issued on January 30, 2026, and NSE's board approval of the IPO plan on February 6, 2026.

Q2. What is the NSE IPO size and structure?

The NSE IPO is structured as a 100% Offer for Sale (OFS) of up to 14.89 crore shares (~6.02% of paid-up capital). The estimated issue size is approximately ₹25,000–30,000 crore, which would make it the largest IPO in Indian history, surpassing Hyundai Motor India's ₹27,859 crore issue. NSE itself receives zero proceeds — all money goes to the selling shareholders.

Q3. What is the NSE IPO price band?

The price band has not yet been announced — it will be disclosed in the Red Herring Prospectus (RHP) after SEBI reviews the DRHP and issues its observations. SEBI's review typically takes 30-75 days. The price band is expected to be announced in August–September 2026. Based on unlisted market prices (~₹1,950–2,050), the implied market cap is approximately ₹5 lakh crore — but the final IPO price may differ.

Q4. When will NSE IPO list on the stock exchange?

NSE is targeting a listing before December 2026 on BSE (NSE cannot list on its own exchange under SEBI rules). If SEBI observations are received by August 2026, the IPO subscription is expected in September–October 2026, with listing approximately 6-10 days after subscription closes.

Q5. What is the NSE IPO valuation?

At current unlisted market prices (~₹2,000 per share), NSE is implied at approximately ₹5 lakh crore market cap — translating to approximately 48-49x FY26 P/E (on PAT of ₹10,302 crore). This is within the range of listed Indian market infrastructure peers (BSE at 55-60x, CDSL at 50-55x) but at the lower end, potentially reflecting a discount for NSE's no-promoter structure and FY26 earnings decline from F&O regulatory tightening.

Q6. Who are the selling shareholders in the NSE IPO OFS?

The largest selling shareholders include SBI (2.48 crore shares), Bank of Baroda (~1.1 crore shares), Stock Holding Corporation of India (~1.1 crore shares), GIC (~1.07 crore shares), New India Assurance (~1.05 crore shares), and National Insurance and United India Insurance (~0.6 crore shares each). Key shareholders NOT selling include LIC (10.72% stake, holding), Premji Invest, Radhakishan Damani, and CPPIB.

Q7. What does the NSE IPO mean for unlisted shareholders?

Unlisted shareholders holding NSE shares continuously since before June 15, 2025 may be eligible to participate in the OFS. Those who bought after this cut-off date are not eligible for the OFS but will receive their shares converted to regular demat shares tradeable on BSE after listing. The key risk for unlisted holders: if the IPO price band is set below current OTC prices (~₹2,000), the unlisted market will correct before listing.

Disclaimer

This article is for informational and educational purposes only and does not constitute investment advice. All data regarding NSE's DRHP, financials, shareholder information, and IPO timeline is based on publicly available information as of July 13, 2026. The NSE IPO price band, subscription dates, and listing date have not yet been officially announced. Unlisted share prices are OTC market-driven and highly volatile. Please conduct independent due diligence and consult a SEBI-registered investment advisor before making any investment decisions related to the NSE IPO.